top of page
Research Article





D Bulanik, B Ozer


ABSTRACT: Aim: The aim of this study was to investigate and compare virulence factors of infection agent enterococci (IE) and flora member enterococci (FME). Methods: A hundred IE isolated from samples sent to microbiology laboratory and 100 FME isolated from the stools were included in the study. Vancomycin susceptibility was investigated by diffusion gradient method (GDM), high level aminoglycoside resistance and beta-lactamase production were investigated by disk diffusion and nitrocefin disk method respectively. Hemolysin, gelatinase and biofilm production were investigated via phenotypic methods. Results and Conclusions: It was found that hemolysin production rate of IE was more than that of FME. Vancomycin MIC values identified by GDM of biofilm-producing strains was found higher than that of biofilm-free  strains. It was also revealed that moxifloxacin and ampicillin resistance rates of biofilm producing FME and ciprofloxacin, penicilin susceptibility of those that not produce biofilms were higher. Hemolysin production in the infectious was 0,37 times more than those in the FME. Biofilm production in the FME was 3,67 times more than that in IE. It was found out that the virulence factors affected resistance of the strains against some antibiotics .The hemolysin production was more in IE. Biofilm production was more in FME.


KEY WORDS: Enterococcus, infectious agent, flora, virulence, slime, hemolysis, gelatinase


  1.  Teixeira L M, Carvalho M G S, Shewmaker P L, Facklam R R. Enterococcus. In:  Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW, eds. Manual of Clinical Microbiology. Washington, D.C.: ASM Press, 2011; 350–64

  2.  Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology 2009; 155:1749-57.

  3.  Mohamed JA, Huang DB. Biofilm formation by enterococci. J Med Microbiol 2007; 56:1581-8.

  4.  Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; Twenty-sixth informational supplement. CLSI document M100-S26. Wayne, PA: Clinical and Laboratory Standards Institute. 2016

  5.  Oluwole DM, Alegbeleye M, Ayeni LE, Famurewa O. Virulence-Marker distribution and antibiotic resistance in Enterococcus spp. Isolated from Tertiary Health Care Facility in Ekiti State, Nigeria. AU J T 2013; 16:247-54

  6.  Marinho AR, Martins PD, Ditmer EM, d’Azevedo PA, Frazzon J. et al. Biofilm formation on polystyrene under different temperatures by antibiotic resistant Enterococcus faecalis and Enterococcus faecium isolated from food. Braz J Microbiol 2013; 44:423-6.

  7.  Stepanović S, Vucović D, Dakić I, Savić B, Švabić-Vlahović M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Meth 2000; 40:175-9

  8.  Sood S, Malhotra M, Das BK, Kapil A. Enterococcal infections & antimicrobial resistance. Indian J Med Res  2008; 128: 111-21

  9.  Fernandes SC, Dhanashree B. Drug resistance & virulence determinants in clinical isolates of Enterococcus species. Indian J Med Res 2013;137:981-5.

  10. Kafil HS, Mobarez AM, Moghadam MF. Adhesion and virulence factor properties of Enterococci isolated from clinical samples in Iran. Indian J Pathol Microbiol 2013; 56:238-42

  11. Sreeja S, Sreenivasa Babu PR, Prathab AG. The Prevalence and the Characterization of the Enterococcus Species from Various Clinical Samples in a Tertiary Care Hospital. J Clin Diag Res 2012;6:1486-8

  12.  Sirin M, Adiloglu A. Comparison of five antimicrobial susceptibility tests in detecting high level aminoglycoside and vancomycin resistances in hospital acquired Enterococcus isolates. Clin Lab 2011;57:157-62.

  13. Yildirim M, Sencan I, Ozdemir D, Oksüz S, Yilmaz Z et al. Vancomycin and high-level aminoglycoside resistant Enterococcus carriage and the risk factors related to resistance in hospitalized patients. Mikrobiyol Bul 2007;41:271-7.

  14. Kilic A, Bedir O, Tunc T, Besirbellioglu B, Eyigun C et al. An outbreak of vanA genotype Enterococcus faecium in pediatric clinic of a training hospital. Mikrobiyol Bul 2009;43:365-72

  15. Comert F, Kulah C, Aktas E, Ozlu N, Celebi G. First isolation of vancomycin-resistant enteroccoci and spread of a single clone in a university hospital in northwestern Turkey. Eur J Clin Microbiol Infect Dis 2007; 26: 57-61

  16. Protonotariou E, Dimitroulia E, Pournaras S, Pitiriga V, Sofianou D et al. Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007. J Hosp Infect 2010;75: 225-7.

  17. Kurtgoz Ozarslan S, B. Ozer, M. Inci, N. Duran, E. Yula. Vancomycin and High-Level Aminoglycoside Resistance in Enterococcus Species. Microbiol Res 2016;7:23-8.

  18. Vazquez-Guillamet C, Kollef M. Treatment of gram-positive infections in critically ill patients. BMC Infect Dis 2014;14:92.

  19. Rathnayake IU, Hargreaves M, Huygens F. Antibiotic resistance and virulence traits in clinical and environmental Enterococcus faecalis and Enterococcus faecium isolates. Syst Appl Microbiol 2012;35:326-33.

  20. Moaddab S, Rafi A. Prevalence of vancomycin and high level aminoglycoside resistant enterococci among high-risk patients. Southeast Asian J Trop Med Public Health 2003;34:849-54

  21. Padmasini E, Padmaraj R, Ramesh SS. High level aminoglycoside resistance and distribution of aminoglycoside resistant genes among clinical ısolates of Enterococcus species in Chennai, India. Scientific World Journal 2014;2014:1-5

  22. Chayakul P, Hortiwakul R, Ingviya N, Chayakul V. Species distribution and antimicrobial susceptibility of enterococci in hospitalized patients in Southern Thailand. J Infect Dis Antimicrob Agents 2007;24:49-54

  23. Akhter S, Asna Z, Rahman M. Prevalence and antimicrobial susceptibility of enterococcus species isolated from clinical specimens. Mymensingh Med J 2011;20:694-9.

  24. Parsek MR, Singh PK. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 2003;57:677-701

  25. del Pozo JL, Patel R. The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther 2007;82:204-9.

  26. Seno Y, Kariyama R, Mitsuhata R, Monden K, Kumon H. Clinical implications of biofilm formation by Enterococcus faecalis in the urinary tract. Acta Med Okayama 2005;59:79-87

  27. Dworniczek E, Wojciech L, Sobieszczanska B, Seniuk A. Virulence of Enterococcus isolates collected in Lower Silesia (Poland). Scand J Infect Dis 2005;37: 630-36.

  28. Baldassari L, Creti R, Recchia S, Pataracchia M, Alfarone G, Orefici G, Campoccia D, Montanaro L, Arciola CR. Virulence factors in enterococcal infections of orthopedic devices. Int J Artif Organs 2006;29:402-6

  29. Kristich CJ, Li T-H, Cvitkovitch DG, Dunny GM. Esp-independent biofilm formation by Enterococcus faecalis. J Bacteriol 2004;186:154-63

  30. Tendolkar PM, Baghdayan AS, Gilmore MS, Shankar N. Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalis. Infect Immun 2004;72:6032-9.

  31. Kafil HS, Mobarez AM. Assessment of biofilm formation by enterococci isolates from urinary tract infections with different virulence profiles. Journal of King Saud University-Science 2015;27:312-7

  32. Tsikrikonis G, Maniatis AN, Labrou M, Ntokou E, Michail G et al. Differences in biofilm formation and virulence factors between clinical and fecal enterococcal isolates of human and animal origin. Microbial Pathogenesis 2012;52:336-43

  33. Di Rosa R, Creti R, Venditti M, D’Amelio R, Arciola CR et al. Relationship between biofilm formation, the enterococcal surface protein (Esp) and gelatinase in clinical isolates of Enterococcus faecalis and Enterococcus faecium. FEMS Microbiol Lett 2006;256:145-50

  34. Johansson D, Rasmussen M. Virulence factors in isolates of Enterococcus faecalis from infective endocarditis and from the normal flora. Microbial Pathogenesis 2013;55:28-31.

 To cite this article:

Bulanik D, Ozer B. Comparison of vancomycin and high level aminoglycoside susceptibilities and virulence factors associated with biofilm of infection agent and flora member enterococcus strains. Int. J. Med. Lab. Res. 2020; 5,2:1-12.

bottom of page